Bio-Industrial Technology Program, Faculty of Agro-Based Industry, Universiti Malaysia Kelantan, Campus Jeli, 17600 Jeli, Kelantan, Malaysia.
Department of Physiology, Faculty of Medicine, University of Malaya, 50603, Lembah Pantai, Kuala Lumpur, Malaysia.
Biomed Pharmacother. 2017 May;89:135-145. doi: 10.1016/j.biopha.2017.02.026. Epub 2017 Mar 24.
Stingless bee honey (SLBH) has been claimed to possess multiple health benefits. Its anti-diabetic properties are however unknown. In this study, ability of SLBH from Geniotrigona thoracica stingless bee species in ameliorating pancreatic damage and in maintaining metabolic profiles were investigated in diabetic condition.
SLBH at 1 and 2g/kg/b.w. was given orally to streptozotocin (STZ)-nicotinamide-induced male diabetic rats for 28days. Metabolic parameters (fasting blood glucose-FBG and lipid profiles-LP and serum insulin) were measured by biochemical assays. Distribution and expression level of insulin, oxidative stress marker i.e. catalase, inflammatory markers i.e. IKK-β, TNF-α, IL-1β and apoptosis marker i.e. caspase-9 in the pancreatic islets were identified and quantified respectively by immunohistochemistry. Levels of NF-κβ in pancreas were determined by enzyme-linked immunoassay (ELISA).
SLBH administration to diabetic male rats prevented increase in FBG, total cholesterols (TC), triglyceride (TG) and low density lipoprotein (LDL) levels. However, high density lipoprotein (HDL) and serum insulin levels in diabetic rats receiving SLBH increased. Additionally, histopathological changes and expression level of oxidative stress, inflammation and apoptosis markers in pancreatic islets of diabetic rats decreased with increased expression level of insulin in the islets. LC-MS analysis revealed the presence of several compounds in SLBH that might be responsible for these effects.
SLBH has great potential to be used as agent to protect the pancreas against damage and dysfunction where these could account for its anti-diabetic properties.
有报道称,无刺蜜蜂蜂蜜(SLBH)具有多种健康益处。然而,其抗糖尿病特性尚不清楚。在这项研究中,研究了来自Geniotrigona thoracica 无刺蜜蜂物种的 SLBH 改善糖尿病状态下胰腺损伤和维持代谢谱的能力。
将 SLBH 以 1 和 2g/kg/b.w. 的剂量口服给予链脲佐菌素(STZ)-烟酰胺诱导的雄性糖尿病大鼠,持续 28 天。通过生化分析测量代谢参数(空腹血糖-FBG 和脂质谱-LP 和血清胰岛素)。通过免疫组织化学分别鉴定和定量胰岛素、氧化应激标志物即过氧化氢酶、炎症标志物即 IKK-β、TNF-α、IL-1β和细胞凋亡标志物即 caspase-9 在胰岛中的分布和表达水平。通过酶联免疫吸附测定(ELISA)测定 NF-κβ 在胰腺中的水平。
SLBH 给药可预防糖尿病雄性大鼠 FBG、总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白(LDL)水平升高。然而,接受 SLBH 的糖尿病大鼠的高密度脂蛋白(HDL)和血清胰岛素水平增加。此外,糖尿病大鼠胰岛中氧化应激、炎症和细胞凋亡标志物的表达水平降低,同时胰岛中胰岛素的表达水平增加,表明 SLBH 可预防糖尿病大鼠胰岛的组织病理学变化。LC-MS 分析表明 SLBH 中存在几种可能负责这些作用的化合物。
SLBH 具有很大的潜力可作为保护胰腺免受损伤和功能障碍的药物,这可能是其抗糖尿病特性的原因。